Insider Buying: Opyl Limited (ASX:OPL) Insider Purchases A$262,003.35 in Stock

Opyl Limited (ASX:OPL) insider Antanas (Tony) Guoga acquired 3,059 shares of the business’s stock in a transaction dated Friday, March 28th. The stock was bought at an average cost of A$85.65 ($51.91) per share, with a total value of A$262,003.35 ($158,789.91).

Opyl Stock Performance

The firm has a market capitalization of $3.28 million, a price-to-earnings ratio of -0.93 and a beta of 1.89.

Opyl Company Profile

Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials.